Literature DB >> 15038727

Chemical genetic control of protein levels: selective in vivo targeted degradation.

John S Schneekloth1, Fabiana N Fonseca, Michael Koldobskiy, Amit Mandal, Raymond Deshaies, Kathleen Sakamoto, Craig M Crews.   

Abstract

Genetic loss of function analysis is a powerful method for the study of protein function. However, some cell biological questions are difficult to address using traditional genetic strategies often due to the lack of appropriate genetic model systems. Here, we present a general strategy for the design and syntheses of molecules capable of inducing the degradation of selected proteins in vivo via the ubiquitin-proteasome pathway. Western blot and fluorometric analyses indicated the loss of two different targets: green fluorescent protein (GFP) fused with FK506 binding protein (FKBP12) and GFP fused with the androgen receptor (AR), after treatment with PROteolysis TArgeting Chimeric moleculeS (PROTACS) incorporating a FKBP12 ligand and dihydrotestosterone, respectively. These are the first in vivo examples of direct small molecule-induced recruitment of target proteins to the proteasome for degradation upon addition to cultured cells. Moreover, PROTAC-mediated protein degradation offers a general strategy to create "chemical knockouts," thus opening new possibilities for the control of protein function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15038727     DOI: 10.1021/ja039025z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  128 in total

1.  Impact of linker length on the activity of PROTACs.

Authors:  Kedra Cyrus; Marie Wehenkel; Eun-Young Choi; Hyeong-Jun Han; Hyosung Lee; Hollie Swanson; Kyung-Bo Kim
Journal:  Mol Biosyst       Date:  2010-10-04

Review 2.  Chemical approaches to controlling intracellular protein degradation.

Authors:  John S Schneekloth; Craig M Crews
Journal:  Chembiochem       Date:  2005-01       Impact factor: 3.164

3.  Small-molecule-mediated rescue of protein function by an inducible proteolytic shunt.

Authors:  Matthew R Pratt; Edmund C Schwartz; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

4.  Molecular tools for cell and systems biology.

Authors:  Carsten Schultz
Journal:  HFSP J       Date:  2007-11-29

5.  Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.

Authors:  A Rodriguez-Gonzalez; K Cyrus; M Salcius; K Kim; C M Crews; R J Deshaies; K M Sakamoto
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

6.  An auxin-based degron system for the rapid depletion of proteins in nonplant cells.

Authors:  Kohei Nishimura; Tatsuo Fukagawa; Haruhiko Takisawa; Tatsuo Kakimoto; Masato Kanemaki
Journal:  Nat Methods       Date:  2009-11-15       Impact factor: 28.547

7.  A functionally orthogonal ligand-receptor pair created by targeting the allosteric mechanism of the thyroid hormone receptor.

Authors:  A Quamrul Hassan; John T Koh
Journal:  J Am Chem Soc       Date:  2006-07-12       Impact factor: 15.419

Review 8.  Targeted Protein Degradation by Small Molecules.

Authors:  Daniel P Bondeson; Craig M Crews
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-10-12       Impact factor: 13.820

9.  Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells.

Authors:  Yue-Qing Tang; Bang-Min Han; Xin-Quan Yao; Yan Hong; Yan Wang; Fu-Jun Zhao; Sheng-Qiang Yu; Xiao-Wen Sun; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2008-12-15       Impact factor: 3.285

Review 10.  Protacs for treatment of cancer.

Authors:  Kathleen M Sakamoto
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.